# IPCA Laboratories Ltd. clinical trials: 30 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials with IPCA Laboratories Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by IPCA Laboratories Ltd.: 30 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ipca-laboratories-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 24, 2013 | NCT01884909 | Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01884909) |
| June 24, 2013 | NCT01884896 | Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01884896) |
| June 24, 2013 | NCT01884857 | Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01884857) |
| April 15, 2013 | NCT01831700 | Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01831700) |
| April 15, 2013 | NCT01831687 | Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01831687) |
| April 15, 2013 | NCT01831674 | Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01831674) |
| April 15, 2013 | NCT01831661 | Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01831661) |
| April 10, 2013 | NCT01827878 | Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01827878) |
| April 10, 2013 | NCT01827865 | Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01827865) |
| December 13, 2012 | NCT01749228 | Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01749228) |
| December 11, 2012 | NCT01746719 | Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01746719) |
| December 7, 2012 | NCT01744873 | Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01744873) |
| December 5, 2012 | NCT01741623 | Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01741623) |
| November 28, 2012 | NCT01735383 | Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01735383) |
| November 28, 2012 | NCT01735370 | Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01735370) |
| November 28, 2012 | NCT01735344 | Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01735344) |
| November 28, 2012 | NCT01735318 | Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01735318) |
| November 6, 2012 | NCT01722201 | Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01722201) |
| November 6, 2012 | NCT01722110 | Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01722110) |
| June 13, 2012 | NCT01618825 | Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01618825) |
| June 13, 2012 | NCT01618799 | Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting State | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01618799) |
| June 13, 2012 | NCT01618760 | Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01618760) |
| May 22, 2012 | NCT01603186 | Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fed | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01603186) |
| May 22, 2012 | NCT01603173 | Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting State | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01603173) |
| May 22, 2012 | NCT01603134 | Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition | IPCA Laboratories Ltd. | Phase 1 | Completed | Fasting State | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01603134) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 30 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 30 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Lecithin Cholesterol Acyltransferase Deficiency | 12 |
| Fasting | 12 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [B2B oil and gas companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-companies/united-states)
- [Irish restaurants in the United States](https://specstream.ai/data/businesses/irish-restaurants/united-states)
- [Video production companies in the United States](https://specstream.ai/data/businesses/video-production-companies/united-states)
- [Fmcg wholesalers in the United States](https://specstream.ai/data/businesses/fmcg-wholesalers/united-states)
- [Shipping and delivery companies in the United States](https://specstream.ai/data/businesses/shipping-and-delivery-companies/united-states)
